| A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. CJ Logothetis, FH Dexeus, L Finn, A Sella, RJ Amato, AG Ayala, ... Journal of Clinical Oncology 8 (6), 1050-1055, 1990 | 767 | 1990 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 520 | 2018 |
| Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial DC Smith, MR Smith, C Sweeney, AA Elfiky, C Logothetis, PG Corn, ... Journal of clinical oncology 31 (4), 412, 2013 | 516 | 2013 |
| Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial T Powles, T Csőszi, M Özgüroğlu, N Matsubara, L Géczi, SYS Cheng, ... The Lancet Oncology 22 (7), 931-945, 2021 | 404 | 2021 |
| Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma … T Powles, MS van der Heijden, D Castellano, MD Galsky, Y Loriot, ... The Lancet Oncology 21 (12), 1574-1588, 2020 | 383 | 2020 |
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ... Annals of Oncology 26 (8), 1589-1604, 2015 | 379 | 2015 |
| Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases JY Ro, AG Ayala, A Sella, ML Samuels, DA Swanson Cancer 59 (3), 516-526, 1987 | 315 | 1987 |
| Chemotherapy with an every‐2‐week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin‐based therapy CN Sternberg, F Calabrò, G Pizzocaro, L Marini, S Schnetzer, A Sella Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 246 | 2001 |
| Chemotherapy for small cell carcinoma of prostatic origin RJ Amato, CJ Logothetis, R Hallinan, JY Ro, A Sella, FH Dexeus The Journal of urology 147 (3), 935-937, 1992 | 222 | 1992 |
| Prostate cancer: ESMO consensus conference guidelines 2012 A Horwich, J Hugosson, T de Reijke, T Wiegel, K Fizazi, V Kataja, ... Annals of oncology 24 (5), 1141-1162, 2013 | 215 | 2013 |
| A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative … RE Kast, JA Boockvar, A Brüning, F Cappello, WW Chang, B Cvek, ... Oncotarget 4 (4), 502, 2013 | 202 | 2013 |
| Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. CJ Logothetis, DE Johnson, C Chong, FH Dexeus, A Sella, S Ogden, ... Journal of Clinical Oncology 6 (10), 1590-1596, 1988 | 198 | 1988 |
| Genetic abnormalities in men with germ cell tumors FH Dexeus, CJ Logothetis, C Chong, A Sella, S Ogden The Journal of urology 140 (1), 80-84, 1988 | 182 | 1988 |
| Collecting duct carcinoma of the kidney MA Dimopoulos, CJ Logothetis, A Markowitz, A Sella, R Amato, J Ro British journal of urology 71 (4), 388-391, 1993 | 174 | 1993 |
| Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract FH Dexeus, CJ Logothetis, A Sella, R Amato, R Kilbourn, K Fitz, A Striegel The Journal of urology 146 (5), 1284-1287, 1991 | 166 | 1991 |
| 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial M Bachner, Y Loriot, M Gross-Goupil, PA Zucali, A Horwich, ... Annals of oncology 23 (1), 59-64, 2012 | 162 | 2012 |
| Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled study D Leibovici, A Zisman, YI Siegel, A Sella, J Kleinmann, A Lindner The Journal of urology 167 (2 Part 1), 563-565, 2002 | 157 | 2002 |
| Renal cell cancer: best recipient of tumor-to-tumor metastasis A Sella, JY Ro Urology 30 (1), 35-38, 1987 | 149 | 1987 |
| Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer. A Sella, R Kilbourn, R Amato, C Bui, AA Zukiwski, J Ellerhorst, ... Journal of clinical oncology 12 (4), 683-688, 1994 | 146 | 1994 |
| Sarcomatoid renal cell carcinoma. A treatable entity A Sella, CJ Logothetis, JY Ro, DA Swanson, ML Samuels Cancer 60 (6), 1313-1318, 1987 | 141 | 1987 |
